Clinical Trials
2 trialsNCT00009919 2013-01-23
SU5416 in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Previous Treatment
National Cancer Institute (NCI)
Phase 2 Terminated
NCT00006384 2011-10-20
SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
City of Hope Medical Center
Phase 2 Completed